Drug Development Research

Papers
(The H4-Index of Drug Development Research is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability57
Potential antiviral activity of isorhamnetin against SARS‐CoV‐2 spike pseudotyped virus in vitro53
Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review46
Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin‐4(3H)‐one derivatives as potential aldose reductase inhibitors41
Role of mineralocorticoid receptor antagonists in kidney diseases40
In vitro enzymatic evaluation of some pyrazolo[1,5‐a]pyrimidine derivatives: Design, synthesis, antioxidant, anti‐diabetic, anti‐Alzheimer, and anti‐arthritic activities with molecular modeling38
Medicinal chemistry of anthranilic acid derivatives: A mini review36
Neuroprotective mechanisms of mangiferin in neurodegenerative diseases29
A new exploration toward adamantane derivatives as potential anti‐MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitors28
Paeoniflorin inhibited nod‐like receptor protein‐3 inflammasome and NF‐κB‐mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR227
Overview of in situ gelling injectable hydrogels for diabetic wounds25
Review of registered clinical trials for the treatment of COVID‐1925
Estradiol reduces ACE2 and TMPRSS2 mRNA levels in A549 human lung epithelial cells25
A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective25
An appraisal of anticancer activity with structure–activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review24
Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors24
Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors24
CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV‐2 infections23
Targeting cyclooxygenase enzyme for the adjuvant COVID‐19 therapy23
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line23
Beyond its anti‐migraine properties, sumatriptan is an anti‐inflammatory agent: A systematic review22
Drug encapsulating polysaccharide‐loaded metal nanoparticles: A perspective drug delivery system21
Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR‐4458 in breast cancer21
Approaches to minimize the effects of P‐glycoprotein in drug transport: A review21
0.055567026138306